ImmunoPrecise Introduces PolyTope mAb Therapy To Tackle Coronavirus Pandemic
IMMUNOPRECISE ANTIBODIES LTD, following its announcement to develop innovative treatments against the new coronavirus, SARS-CoV-2, unveils its unique approach utilizing PolyTope mAb Therapy™, enabled by IPA’s diverse discovery platforms and artificial intelligence capabilities with their partner, EVQLV, Inc., in the development of a universal COVID-19
Global Pharma | 15/03/2020 | By Darshana | 336
Covid-19: Pharma companies ask Govt to lift API's export restrictions
Pharmaceutical lobby groups have urged the government to lift restrictions on export of active pharmaceutical ingredients (APIs) and formulations, saying they have enough stock and there will be no shortage of these formulations in India amid the coronavirus outbreak
Global Pharma | 12/03/2020 | By Darshana | 353
Torrent Pharmaceuticals puts faith in local market, to focus on new drug launches
Torrent Pharmaceuticals is optimistic that the future of Indian drug makers is in the domestic market, as it looks at new launches in the lucrative chronic therapy areas
Global Pharma | 12/03/2020 | By Darshana | 398
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy